-
Human CD8⁺ and CD4⁺ T cell memory to lymphocytic choriomeningitis virus infection.
J VirolKotturi MF, Swann JA, Peters B, Arlehamn CL, Sidney J, Kolla RV, James EA, Akondy RS, Ahmed R, Kwok WW, Buchmeier MJ, Sette A -
Low-dose antigen promotes induction of FOXP3 in human CD4+ T cells.
Journal of ImmunologyLong SA, Rieck M, Tatum M, Bollyky PL, Wu RP, Muller I, Ho JC, Shilling HG, Buckner JH -
IgE induces transcriptional regulation of thymic stromal lymphopoietin in human airway smooth muscle cells.
The Journal of Allergy and Clinical ImmunologyRedhu NS, Saleh A, Lee HC, Halayko AJ, Ziegler SF, Gounni AS -
Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients.
Arthritis RheumSnir O, Rieck M, Gebe JA, Yue BB, Rawlings CA, Nepom G, Malmström V, Buckner JH -
Regulatory T cells GATA have it.
ImmunityCampbell DJ -
CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game.
Journal of ImmunologyLong SA, Buckner JH -
Metabolic tests to determine risk for type 1 diabetes in clinical trials.
Diabetes/Metabolism Research and ReviewsGreenbaum CJ, Buckingham B, Chase HP, Krischer J, Diabetes Prevention Trial, Type 1 Diabetes (DPT-1) Study Group. -
The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.
The Journal of Clinical InvestigationMenard L, Saadoun D, Isnardi I, Ng YS, Meyers G, Massad C, Price C, Abraham C, Motaghedi R, Buckner JH, Gregersen PK, Meffre E -
Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation.
ImmunityReardon C, Lechmann M, Brüstle A, Gareau MG, Shuman N, Philpott D, Ziegler SF, Mak TW -
Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells.
Journal of ImmunologyMattapallil MJ, Silver PB, Mattapallil JJ, Horai R, Karabekian Z, McDowell JH, Chan CC, James EA, Kwok WW, Sen HN, Nussenblatt RB, David CS, Caspi RR -
TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation.
NatureSiracusa MC, Saenz SA, Hill DA, Kim BS, Headley MB, Doering TA, Wherry EJ, Jessup HK, Siegel LA, Kambayashi T, Dudek EC, Kubo M, Cianferoni A, Spergel JM, Ziegler SF, Comeau MR, Artis D -
Treg cells: patrolling a dangerous neighborhood.
Nat MedCampbell DJ, Koch MA -
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study.
Diabetes CareSosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP, Type 1 Diabetes TrialNet and Diabetes Prevention Trial-Type 1 Study Groups. -
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
LancetOrban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Raskin P, Rodriguez H, Russell WE, Schatz D, Wherrett D, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet Abatacept Study Group. -
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
LancetWherrett DK, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Herold KC, Marks JB, Monzavi R, Moran A, Orban T, Palmer JP, Raskin P, Rodriguez H, Schatz D, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet GAD Study Group.
